BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36189550)

  • 21. Uterine involvement in epithelial ovarian cancer and its risk factors.
    Zamani N; Mousavi AS; Akhavan S; Sheikhhasani S; Nikfar S; Feizabad E; Rezayof E; Modares Gilani M
    J Ovarian Res; 2021 Dec; 14(1):171. PubMed ID: 34876191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinico-pathologic characteristics and prognostic factors of ovarian carcinoma with different histologic subtypes - A benchmark analysis of 482 cases.
    Brambs CE; Höhn AK; Klagges S; Gläser A; Taubenheim S; Dornhöfer N; Einenkel J; Hiller GGR; Horn LC
    Pathol Res Pract; 2022 May; 233():153859. PubMed ID: 35378355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum LDH and CA-125: Markers for Diagnosis of Ovarian Malignancy.
    Deeba F; Khatun S; Alam MM; Shahida SM
    Mymensingh Med J; 2015 Apr; 24(2):334-40. PubMed ID: 26007262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of histopathology in diagnosis of ovarian neoplasms: Our experience in a Tertiary Care Hospital of Kolkata, West Bengal, India.
    Chakrabarti PR; Chattopadhyay M; Gon S; Banik T
    Niger Postgrad Med J; 2021; 28(2):108-111. PubMed ID: 34494596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic features of ovarian neoplasms with emphasis on borderline ovarian tumors: an institutional perspective.
    Hashmi AA; Hussain ZF; Bhagwani AR; Edhi MM; Faridi N; Hussain SD; Khan M
    BMC Res Notes; 2016 Apr; 9():205. PubMed ID: 27052022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
    Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
    Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epithelial ovarian tumors in adolescence: a study of clinical features and treatment].
    Li M; Pan LY; Huang HF; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):598-601. PubMed ID: 15498186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical characteristics of borderline ovarian tumors and stage I epithelial ovarian cancer: an analysis of 143 cases].
    Zhao Y; Wang Y; Shen Dh; Song Rn; Xu Q; Li Y; Cui H; Tang J; Wei Lh
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 43(1):123-8. PubMed ID: 21321635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial ovarian cancer at a cancer hospital in a developing country.
    Sarwar CM; Siddiqui N; Khokhar RA; Badar F
    Asian Pac J Cancer Prev; 2006; 7(4):595-8. PubMed ID: 17250434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer.
    Zhang W; Wang L; Xin Z
    Medicine (Baltimore); 2018 Apr; 97(16):e0358. PubMed ID: 29668586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?
    Sahin H; Meydanli MM; Sari ME; Yalcin I; Çoban G; Ozkan NT; Cuylan ZF; Erdem B; Gungorduk K; Akbayir Ö; Dede M; Salman MC; Güngör T; Ayhan A
    J Ovarian Res; 2018 Mar; 11(1):21. PubMed ID: 29506569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presenting signs and symptoms of ovarian cancer at a tertiary care hospital.
    Khan A; Sultana K
    J Pak Med Assoc; 2010 Apr; 60(4):260-2. PubMed ID: 20419965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gynecological malignancies at tertiary care hospital, Pakistan: A five-year review.
    Wasim T; Mushtaq J; Wasim AZ; Raana GE
    Pak J Med Sci; 2021; 37(3):621-627. PubMed ID: 34104137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential).
    Scully RE
    Bull Cancer; 1982; 69(3):228-38. PubMed ID: 6289947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinicalpathological characteristics of Lynch syndrome related epithelial ovarian cancer].
    Ma XG; Wang YM; Xue FX; Zhang HY; Sheng HN; Qi Z; Liu GY
    Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):201-4. PubMed ID: 22781072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasound features and clinical outcome of patients with malignant ovarian masses diagnosed during pregnancy: experience of a gynecological oncology ultrasound center.
    Moro F; Mascilini F; Pasciuto T; Leombroni M; Li Destri M; De Blasis I; Garofalo S; Scambia G; Testa AC
    Int J Gynecol Cancer; 2019 Sep; 29(7):1182-1194. PubMed ID: 31326950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical characteristics and prognosis of epithelial ovarian cancer in young women].
    Tang L; Zheng M; Xiong Y; Ding H; Liu FY
    Ai Zheng; 2008 Sep; 27(9):951-5. PubMed ID: 18799034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective study of 27 ovarian tumors of low malignant potential.
    Demeter A; Csapó Z; Szánthó A; Bálega J; Sipos N; Papp Z
    Eur J Gynaecol Oncol; 2002; 23(5):415-8. PubMed ID: 12440814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian Tumors: Pattern of Histomorphological Types- A 10 Years Study in a Tertiary Referral Center and Review of Literature.
    Ghosh A; Ghartimagar D; Thapa S; Sathian B; Narasimhan R; Talwar OP
    Kathmandu Univ Med J (KUMJ); 2016; 14(54):153-158. PubMed ID: 28166073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal surgery in treatment of advanced ovarian cancer--review of our experience.
    Stefanović A; Jeremić K; Kadija S; Milincić N; Mircić A; Petković S; Zizić V
    Eur J Gynaecol Oncol; 2011; 32(4):419-22. PubMed ID: 21941966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.